Evelyn Flanagan

418 total citations
14 papers, 166 citations indexed

About

Evelyn Flanagan is a scholar working on Pulmonary and Respiratory Medicine, Geriatrics and Gerontology and Endocrine and Autonomic Systems. According to data from OpenAlex, Evelyn Flanagan has authored 14 papers receiving a total of 166 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Geriatrics and Gerontology and 3 papers in Endocrine and Autonomic Systems. Recurrent topics in Evelyn Flanagan's work include Cystic Fibrosis Research Advances (4 papers), Frailty in Older Adults (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Evelyn Flanagan is often cited by papers focused on Cystic Fibrosis Research Advances (4 papers), Frailty in Older Adults (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Evelyn Flanagan collaborates with scholars based in Ireland, United Kingdom and Italy. Evelyn Flanagan's co-authors include Joseph A. Eustace, J. R. Power, Patricia M. Kearney, Mike Clarke, Edward J. Johns, Caroline Hurley, Frances Shiely, Mirko Petrović, Amanda Lavan and Roy L. Soiza and has published in prestigious journals such as Scientific Reports, International Journal of Environmental Research and Public Health and Journal of Infection.

In The Last Decade

Evelyn Flanagan

13 papers receiving 162 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Evelyn Flanagan Ireland 7 58 38 36 34 31 14 166
Suhaj Abdulsalim Saudi Arabia 8 31 0.5× 46 1.2× 23 0.6× 32 0.9× 23 0.7× 21 212
Milena Kovačević Serbia 8 92 1.6× 20 0.5× 10 0.3× 41 1.2× 22 0.7× 25 186
CB Tripathi India 9 61 1.1× 21 0.6× 17 0.5× 15 0.4× 38 1.2× 22 331
Christiane Verny France 10 59 1.0× 7 0.2× 27 0.8× 24 0.7× 19 0.6× 23 252
Geert ‘t Jong Canada 6 10 0.2× 23 0.6× 39 1.1× 20 0.6× 40 1.3× 16 246
Janet Onopa United States 7 76 1.3× 23 0.6× 36 1.0× 35 1.0× 7 0.2× 8 344
Ameha Zewudie Ethiopia 10 36 0.6× 12 0.3× 7 0.2× 8 0.2× 26 0.8× 16 248
Christie Schumacher United States 7 55 0.9× 17 0.4× 43 1.2× 16 0.5× 31 1.0× 32 315
Sophie Renet France 9 29 0.5× 21 0.6× 9 0.3× 11 0.3× 6 0.2× 24 201
A. J. Birtwell United Kingdom 7 30 0.5× 15 0.4× 25 0.7× 22 0.6× 21 0.7× 9 269

Countries citing papers authored by Evelyn Flanagan

Since Specialization
Citations

This map shows the geographic impact of Evelyn Flanagan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evelyn Flanagan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evelyn Flanagan more than expected).

Fields of papers citing papers by Evelyn Flanagan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evelyn Flanagan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evelyn Flanagan. The network helps show where Evelyn Flanagan may publish in the future.

Co-authorship network of co-authors of Evelyn Flanagan

This figure shows the co-authorship network connecting the top 25 collaborators of Evelyn Flanagan. A scholar is included among the top collaborators of Evelyn Flanagan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evelyn Flanagan. Evelyn Flanagan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
O’Donovan, Mark, et al.. (2025). Pharmacological and Non-Pharmacological Interventions to Improve Sleep in People with Cognitive Impairment: A Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health. 22(6). 956–956. 3 indexed citations
2.
Boyle, Douglas, et al.. (2024). Co-designing a virtual reality exposure therapy with students experiencing school anxiety: a proof-of-concept study. Irish Journal of Psychological Medicine. 41(4). 469–477.
3.
O’Donovan, Mark, et al.. (2023). Diagnostic Accuracy of Frailty Screening Instruments Validated for Use among Older Adults Attending Emergency Departments: A Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health. 20(13). 6280–6280. 12 indexed citations
4.
Sezgin, Duygu, Mark O’Donovan, Aaron Liew, et al.. (2022). The Diagnostic Accuracy and Clinimetric Properties of Screening Instruments to Identify Frail Older Adults Attending Emergency Departments: A Protocol for a Mixed Methods Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health. 19(3). 1380–1380. 8 indexed citations
5.
Deane, Jennifer, Fiona Fouhy, N.J. Ronan, et al.. (2021). A multicentre analysis of Clostridium difficile in persons with Cystic Fibrosis demonstrates that carriage may be transient and highly variable with respect to strain and level. Journal of Infection. 82(3). 363–370. 3 indexed citations
7.
Einarsson, G.G., Evelyn Flanagan, Clodagh McGettigan, et al.. (2019). WS19-3 Microbiota profiling during 1-year of clinical stability in people with cystic fibrosis - CFMATTERS Consortium. Journal of Cystic Fibrosis. 18. S35–S35. 3 indexed citations
9.
Fouhy, Fiona, N.J. Ronan, Órla O’Sullivan, et al.. (2017). A pilot study demonstrating the altered gut microbiota functionality in stable adults with Cystic Fibrosis. Scientific Reports. 7(1). 6685–6685. 36 indexed citations
10.
Lavan, Amanda, Joseph A. Eustace, Darren Dahly, et al.. (2017). Incident adverse drug reactions in geriatric inpatients: a multicentred observational study. Therapeutic Advances in Drug Safety. 9(1). 13–23. 23 indexed citations
11.
Hurley, Caroline, Frances Shiely, J. R. Power, et al.. (2016). Risk based monitoring (RBM) tools for clinical trials: A systematic review. Contemporary Clinical Trials. 51. 15–27. 30 indexed citations
12.
Connell, Louise C., et al.. (2012). Does age count in pancreatic resection? An Irish experience. Journal of Geriatric Oncology. 3. S101–S101. 1 indexed citations
13.
Cope, Georgina, Evelyn Flanagan, Belinda L. Houghton, et al.. (2012). [Nle3,d‐Phe6]‐γ2‐melanocyte‐stimulating hormone possesses the renal excretory but not the cardiovascular actions of the native γ2‐melanocyte‐stimulating hormone in anaesthetized rats. Clinical and Experimental Pharmacology and Physiology. 40(1). 5–12. 3 indexed citations
14.
Flanagan, Evelyn, et al.. (2008). Impact of cardiac hypertrophy on arterial and cardiopulmonary baroreflex control of renal sympathetic nerve activity in anaesthetized rats. Experimental Physiology. 93(9). 1058–1064. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026